Company profile for Enleofen Bio Pte

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Enleofen Bio is a biotechnology company that focuses on developing first-in-class antibody therapeutics for the treatment of fibrotic human diseases. Following the breakthrough discovery in the importance of interleukin 11 as a main driver of fibrosis, Enleofen was founded as a spin-out from National Heart Centre Singapore, SingHealth and Duke-NUS Medical School with Series A funding to translate research findings into treatme...
Enleofen Bio is a biotechnology company that focuses on developing first-in-class antibody therapeutics for the treatment of fibrotic human diseases. Following the breakthrough discovery in the importance of interleukin 11 as a main driver of fibrosis, Enleofen was founded as a spin-out from National Heart Centre Singapore, SingHealth and Duke-NUS Medical School with Series A funding to translate research findings into treatments that will improve and save the lives of millions of patients worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
160 Robinson Road, SBF Centre, # 23-02, Singapore 068914
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty